You just read:

Arena Pharmaceuticals to Present Phase 1 and Preclinical Data on APD371 in Development for Treatment of Pain Associated with Crohn's Disease at American Pain Society Annual Scientific Summit

News provided by

Arena Pharmaceuticals, Inc.

Mar 01, 2018, 08:30 ET